M, A., Z, C., P, C., M, C., RO, C., L, G., . . . A, W. (2022). Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO). European journal of cancer (Oxford, England : 1990), 166, 126. https://doi.org/10.1016/j.ejca.2022.01.028
Chicago Style (17th ed.) CitationM, Aapro, et al. "Assessing the Impact of Antiemetic Guideline Compliance on Prevention of Chemotherapy-induced Nausea and Vomiting: Results of the Nausea/emesis Registry in Oncology (NERO)." European Journal of Cancer (Oxford, England : 1990) 166 (2022): 126. https://doi.org/10.1016/j.ejca.2022.01.028.
MLA (9th ed.) CitationM, Aapro, et al. "Assessing the Impact of Antiemetic Guideline Compliance on Prevention of Chemotherapy-induced Nausea and Vomiting: Results of the Nausea/emesis Registry in Oncology (NERO)." European Journal of Cancer (Oxford, England : 1990), vol. 166, 2022, p. 126, https://doi.org/10.1016/j.ejca.2022.01.028.